The Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Trial The Value of Remote Monitoring

Similar documents
Remote monitoring: how to remove barriers and implement advances. Prof Haran Burri Electrophysiology Unit University Hospital of Geneva

and CRM devices: Finland

CLINICIAN MANUAL. LATITUDE Patient Management System

Medtronic CareLink Network :: PACE article: Remote monitoring of ICDs: A prospective analysis Abstract Introduction

Initial Clinic Setup Reference Guide. Merlin.net Patient Care Network (PCN)

Remote Monitoring for Cardiac Arrhythmia: Its Legacy and Growing Importance in Advancing Clinical and Economic Outcomes

Remote monitoring: a cost or an investment?

TIPS AND TRICKS FOR ALERT MANAGEMENT. Reveal LINQ Insertable Cardiac Monitoring System

Evaluation of Telestroke Services

Anticoagulation in a nurse-led AF-Clinic

Key Clinical Trials and Mega Cohort Studies in the Area of Remote Monitoring. Lifetime of Patient Care. Lifetime of Patient Care.

PREVENTING THE SPREAD OF C.DIFF WITH AUTOMATED HAND HYGIENE SOLUTIONS. BY KEVIN WITTRUP and MIKE BURBA

How 2018 Will Be The Year You Embrace Continuous Connectivity. NERSI NAZARI, PHD Chief Executive Officer

CLINICIAN MANUAL LATITUDE NXT. LATITUDE NXT Patient Management System

Apps at the Point Of Care

Using Predictive Analytics to Improve Sepsis Outcomes 4/23/2014

Best Practices for emeasure Implementation. Breakout Session #2: Implementation in Office-Based Practice Settings

REVEAL LINQ OPTIMIZING PATIENT EDUCATION

LATITUDE. Patient Management System

Atrial Fibrillation: 2017 Update & Specialty Clinic Focus

CLINICAL MEDICAL POLICY

INTEGRATING EMR SOLUTIONS FOR ENHANCED CARE COORDINATION A PATIENT S JOURNEY

Standards for insertion, follow up and explant of implantable loop recorders [ILRs] by non-medical staff

Better Medical Device Data Yield Improved Care The benefits of a national evaluation system

Journal of Interventional Cardiac Electrophysiology An International Journal of Cardiac Arrhythmias and Rhythm Management ISSN X

Quality ID #348: HRS-3 Implantable Cardioverter-Defibrillator (ICD) Complications Rate National Quality Strategy Domain: Patient Safety

ADVANTAGES PRACTICES EXPERIENCE USING REMOTE MONITORING; A PRACTICE VALUE CASE STUDY

10/26/2017. Incorporating NPs into an EP Practice. Karla Rusk, MS, CCRN, ANP-BC, ACNP-BC Lead Nurse Practitioner, Electrophysiology. Disclosures.

ICMJE Form for Disclosure of Potential Conflicts of Interest

Quality Payment Program MIPS. Advanced APMs. Quality Payment Program

SIMPLE SOLUTIONS. BIG IMPACT.

GET STARTED WITH YOUR REVEAL LINQTM SYSTEM. Patient Setup Guide

Utilizing a Pharmacist and Outpatient Pharmacy in Transitions of Care to Reduce Readmission Rates. Disclosures. Learning Objectives

Implantable Medical Devices:

CARDIAC DEVICE MONITORING

REVIEW OF PROVIDENCE ALASKA MEDICAL CENTER CERTIFICATE OF NEED APPLICATION FOR CONSTRUCTION OF AN ELECTROPHYSIOLOGY LABORATORY

The Role of the Arrhythmia Nurse

Heart Failure Clinic a Multidisciplinary approach. Amy Benson, PA-C, MSPAS Presbyterian Heart Group Albuquerque, NM

ABOUT REVEAL LINQ DURING

Effects of Patient Load and Other Monitoring System Design Choices on Inpatient Monitoring Quality

Implementation of Student Pharmacist-Led Anticoagulation Counseling

MONITORING PATIENTS. Responding to Readings

MOC Part IV: Your Guide to Making it Happen.

SENTARA HEALTHCARE. Norfolk, VA

Developing a successful EP service line / practice

National Institutes of Health, National Heart, Lung and Blood Institute (NHLBI)

Veterans Health Administration: Surveillance of Cardiovascular Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease

HMSA Physical and Occupational Therapy Utilization Management Guide

INTERMACS has a Key Role in Reporting on Quality Metrics

17/06/2018. None. Author/s: Andrea Taylor Date of issue: 17 June 2015

The pathway highlights a clear strategy for managing these patients which includes the following:

Lars Wallentin, Salim Yusuf, Michael Ezekowitz, Sean Young, Janice Pogue, Stuart Connolly, for the RELY Investigators

CME/CNE Evaluation & Certification Instructions

Telehealth in Peritoneal Dialysis Patient Management

SHP Access 6/7/2016. Objectives. SHP Alerts. You will need a user name and password

Secondary Care. Chapter 14

Deactivation of Implantable Cardioverter Defibrillators (ICD) at the end of life (Guideline)

Payer s Perspective on Clinical Pathways and Value-based Care

Falls Prevention In Rehabilitation

Routine Data Is it Good Enough for Trials. Alex Wright-Hughes Wednesday, May 23, 2012

Trust Policy and Procedure Document Ref. No: PP (17) 283. Central Alerting System (CAS) Policy and Procedure. For use in: For use by: For use for:

ACC State Chapters Best Practice Guide. Working with States on Clinical Data Requests

FLORIDA DEPARTMENT OF CORRECTIONS OFFICE OF HEALTH SERVICES HEALTH SERVICES BULLETIN NO Page 1 of 8

Follow this and additional works at: Part of the Nursing Commons

The Liverpool Live Cardiac Resynchronisation Therapy (CRT) Course

Referred Patient Alerts & Online Recruitment Manager for Sites Instructions

The Veterans Health Administration CART Program: Integration of Real-Time Data Collection into the Process of Clinical Care

Heart Failure Order Sets. Standardizing Care for the Heart Failure Patient 2012

University of Wisconsin Madison Cardiovascular Medicine Fellowship Cardiac Electrophysiology Rotation Goals and Objectives

Operational policy on Deactivating ICD s at End of Life.

Dobson DaVanzo & Associates, LLC Vienna, VA

HMSA Physical and Occupational Therapy Utilization Management Authorization Guide

Preventing Heart Failure Readmissions by Using a Risk Stratification Tool

Remote Monitoring Solutions

Hand-hygiene Systems Provide Compliance Help

When to Consider Implantable Cardioverter Defibrillator (ICD) Deactivation. A Guide for Patients and Family

When to Consider Implantable Cardioverter Defibrillator (ICD) Deactivation. A Guide for Patients and Family

Dobson DaVanzo & Associates, LLC 440 Maple Avenue East, Suite 203, Vienna, VA

Using BIOVIGIL Technology to Improve Hand Hygiene Compliance and Awareness. by Kevin Wittrup Research by Mike Burba

CARESCAPE Central Station Powerful insight. Streamlined design.

Warfarin or NOACs Lessons from real-life data in different countries. Giuseppe Patti Campus Bio-Medico University of Rome

implementing a site-neutral PPS

Cardiology Published: March 2015 Review date: March 2018 Reference no: 2532v1 Imperial College Healthcare NHS Trust

Sustaining Open Access. Annie Jensen LCSW Clinical Consultant, MTM Services

A Comparative Effectiveness Trial Warfarin versus Direct Oral Anti- Coagulants. Thomas L. Ortel, M.D., Ph.D. 2 December 2016

The impact of the heart failure health enhancement program: A retrospective pilot study

SUPPORTING DOCUMENTATION FINDINGS OP THE SENATE SPECIAL COMMITTEE ON AGING THE MEDICARE SICKER-QUICKER PHENOMENON

Therapies (e.g., physical, occupational and speech) Medical social worker (MSW) 3328ALL0118-F 1

The CART Transactional Approach

MSTS 2018 Abstract Submission Guidelines

Trends in Family Caregiving and Why It Matters

The North Carolina Behavioral Health Crisis Referral System

SPRAGUE SCHOOL DISTRICT Baltic, Connecticut ADMINISTRATIVE REGULATIONS REGARDING AUTOMATIC EXTERNAL DEFIBRILLATORS

Wilhide Consulting, Inc. (c) 1

De-identification and Clinical Trials Data: Oh the Possibilities!

Early Recognition of In-Hospital Patient Deterioration Outside of The Intensive Care Unit: The Case For Continuous Monitoring

VTE Prevention. Workflow Processes

Pragmatic Trial Designs Capturing Endpoints and Integrating Data from Non-Linked Sources

Patient-Centered Specialty Practice (PCSP) Recognition Program

MLN Matters Number: MM6699 Related Change Request (CR) #: 6699

Transcription:

The Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Trial The Value of Remote Monitoring George H. Crossley, MD President, Mid State Cardiology, a unit of St. Thomas Heart Clinical Professor of Medicine, University of Tennessee College of Medicine ACC Governor, Tennessee

Disclosures CONSULTING FEES/HONORARIA Medtronic Inc Boeringer SPEAKER'S BUREAU Medtronic Sanofi RESEARCH/RESEARCH GRANTS Medtronic St Jude Sanofi

Study Purpose To demonstrate that remote monitoring with automatic clinician notifications reduces the time from a clinical event to a clinical decision in response to arrhythmias, cardiovascular disease progression, and device issues as compared to standard in-office care. Rates of cardiovascular health care utilization (HCU) between treatment groups

Study Design Randomized, multi-center prospective study N = 1,997 newly implanted CRT-D and DR-ICD patients 136 US centers Remote management system vs. standard In-office care Patients followed remotely for 12 months (Remote Arm) Patient signs Informed Consent/HIPAA Authorization implanted with a study device and randomized Remote Arm 1014 pts Enrollment 1 Month Office F/U In office Arm 983 pts Enrollment 1 Month Office F/U 3 Month Remote F/U 3 Month Office F/U 6 Month Remote F/U 6 Month Office F/U 9 Month Remote F/U 9 Month Office F/U 12 Month Remote F/U 12 Month Office F/U 15 Month Office F/U 15 Month Office F/U Crossley G, Boyle A, Vitense H, Sherfesee L, Mead RH. Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: the Clinical evaluation Of remote NotificatioN to reduce Time to clinical decision (CONNECT) study. Am Heart J. 2008 Nov;156(5):840-6. Epub 2008 Sep 11.

Required Study Programming Remote In office Medtronic CareLink Home Monitor Provided Not Provided Clinical Management Alerts AT/AF Burden Automatic Clinician Alert, 12 hrs/day Off Fast V. Rate during AT/AF Automatic Clinician Alert, 120 bpm x 6 hrs AT/AF /day Off Number of Shocks Delivered Automatic Clinician Alert, 2 Shocks Delivered Off All Therapies Exhausted in a Zone Automatic Clinician Alert Off Lead / Device Integrity Alerts Lead Impedance Out of Range Automatic Clinician and Audible Patient Alert Audible Patient Alert VF Detection / Therapy Off Automatic Clinician and Audible Patient Alert Audible Patient Alert Low Battery Voltage Automatic Clinician and Audible Patient Alert Audible Patient Alert Excessive Charge Time Automatic Clinician and Audible Patient Alert Audible Patient Alert

Required Study Programming Atrial fibrillation Midnight Day 1 Midnight Day 2 Midnight Day 3 Atrial fibrillation Midnight Day 1 Midnight Day 2 Midnight Day 3

Required Study Programming Remote In office Medtronic CareLink Home Monitor Provided Not Provided Clinical Management Alerts AT/AF Burden Automatic Clinician Alert, 12 hrs/day Off Fast V. Rate during AT/AF Automatic Clinician Alert, 120 bpm x 6 hrs AT/AF /day Off Number of Shocks Delivered Automatic Clinician Alert, 2 Shocks Delivered Off All Therapies Exhausted in a Zone Automatic Clinician Alert Off Lead / Device Integrity Alerts Lead Impedance Out of Range Automatic Clinician and Audible Patient Alert Audible Patient Alert VF Detection / Therapy Off Automatic Clinician and Audible Patient Alert Audible Patient Alert Low Battery Voltage Automatic Clinician and Audible Patient Alert Audible Patient Alert Excessive Charge Time Automatic Clinician and Audible Patient Alert Audible Patient Alert

Study Methods All events that did or would have triggered alerts if device programmed accordingly included Events that triggered alerts: the center logged date of clinical decision Events that did not trigger alerts: date of decision was date of first device interrogation following event Time to decision determined for each event, and for each subject with an event, these times were averaged Due to skewness of data, nonparametric test used to compare time to decision per patient between arms For health care utilization, multiple events proportional hazards models used to compare rates of each of the following between arms: Cardiovascular hospitalizations ED visits Unscheduled clinic visits, including urgent care visits

Study Demographics Patient Characteristics Remote (n=1014) In office (n=983) Male 70.5% 71.7% Age (years) 65.2 ± 12.4 64.9 ± 11.9 CRT D 36.4% 35.3% LVEF (%) 28.6 ± 10.0 29.2 ± 10.3 NYHA No HF Class I Class II Class III Class IV 5.3% 3.9% 40.9% 48.5% 1.5% 6.7% 4.7% 39.5% 47.5% 1.5%

Primary Endpoint Time from event to clinical decision in the Remote Arm was significantly shorter than in the In office Arm (p<0.001) Event to Clinical Decision (median time) (per patient with at least one event) Median time in the Remote arm was 4.6 days vs. 22 days in the In office arm Note: Data includes events for patients who crossed over, were noncompliant or had alerts occur prior to home monitor setup

Time from Event to Decision by Alert Type (median days) Device Event No. of Events (No. of Patients) No. of Days from Event Onset To Clinical Decision Median (Interquartile Range) Remote In office Remote In office AT/AF burden at least 12 hrs 437 (107) 280 (105) 3 (1, 15) 24 (7, 57) Fast V rate at least 120 bpm during at least 6 hrs AT/AF 41 (26) 47 (37) 4 (2, 13) 23 (5, 40) At least 2 shocks delivered in an episode 44 (35) 32 (23) 0 (0, 1.5) 0 (0, 2) Lead impedances out of range 26 (18) 12 (6) 0 (0, 9) 17 (5.5, 45) All therapies in a zone exhausted for an episode 16 (12) 11 (6) 0 (0, 1) 9 (0, 36) VF detection/therapy off 10 (10) 8 (8) 0 (0, 0) 0 (0, 84) Low battery 1 (1) 1 (1) 30 0 Overall 575 (172) 391 (145) 3 (0, 13) 20 (4, 52)

Results of Clinician Alert Transmissions Clincian alert unable to transmit due to other reasons (patient not home, monitor not plugged in, etc.) 9% Clinician alert unable to transmit due to home monitor not set up 25% (Remote Arm) Successful clinician alert transmission & device data viewed prior to clinicial decision 41% Patient seen inoffice prior to clincian alert transmission 13% Successful clinician alert transmission but decision made prior to viewing data 12%

Clinician Alert Transmissions

Clinic Visits (Scheduled and Unscheduled) By replacing routine clinic visits with remote monitoring, the observed rate of total clinic visits per patient year was Remote (3.92) vs. In office (6.27)

Health Care Utilization Visits by Treatment Arm * Includes Urgent Care Visits

Impact of Remote Management This study showed the Remote Arm had significantly shorter hospitalization length of stays than In office Arm (p=0.002) Remote Arm = 3.3 days per hospitalization In office Arm = 4 days per hospitalization Mean reduction 18% Estimated savings per hospitalization $1,659* (p = 0.002) * Estimated using the Medicare Limited Data Set Standard Analytic Files from 2002 2007

Conclusions In this study monitoring patients remotely with automatic clinician alerts showed: A significant reduction in time from onset of events to clinical decisions in response to arrhythmias, and device issues Replacement of routine in clinic visits with remote transmissions did not significantly increase other health care utilizations (cardiovascular hospitalizations, emergency department, and unscheduled clinic visits) A significant reduction in mean length of stay per cardiovascular hospitalization